Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 141 - 160 of 289
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Mar 2012, 9:02 am by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989)(“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
4 Aug 2014, 2:13 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]), the Eleventh Circuit U.S. [read post]
25 Aug 2014, 10:23 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579 [1993]).Admissibility of Accident Reconstruction Expert:Judge Timothy G. [read post]
27 Jul 2017, 2:00 am
MERRELL DOW PHARMACEUTICALS, INC 509 U.S. 579 (1993)KOKKONEN V. [read post]
17 Jan 2014, 8:27 pm by Alex Craigie
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
31 Dec 2009, 2:34 am by Sean Wajert
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its federal and state progeny. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
6 Apr 2016, 12:06 pm by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
21 Mar 2019, 4:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which listed several factors that a court may consider when determining the admissibility of an expert. [read post]
13 Jun 2017, 4:00 am by Jeff Welty
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
25 Jan 2012, 6:42 am by emagraken
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786 (1993), and discussed in Taylor v. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
24 Oct 2017, 6:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which is also codified in Rule 702 of the Federal Rules of Evidence. [read post]